{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#27 – Greg Divis, CEO Of Avadel Pharmaceuticals","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/228b5baf\"></iframe>","width":"100%","height":180,"duration":985,"description":"Join us on the latest episode! Our Guest: Greg Divis, CEO at Avadel Pharmaceuticals\nWhat you'll get out of this episode:\nDiscussing LUMRYZ, a new narcolepsy drug.\nInsights into the challenges of narcolepsy treatment.\nAvadel's future plans in healthcare innovation.\n\nTo learn more about Greg and Avadel Pharmaceuticals:\nGuest LinkedIn: https://www.linkedin.com/in/greg-divis-a525334/\nWebsite: https://www.avadel.com/\nCompany LinkedIn: https://www.linkedin.com/company/avadelpharmaceuticals/\n\nOur sponsor for this episode are:\nSage Growth Partners https://sage-growth.com/\nBioBreakthroughs is part of the Slice of Healthcare podcast network:\nLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}